n,1-Ditritylhistidine is a heavily protected histidine derivative designed to block both ring and backbone functionalities. The bulky trityl groups support selective downstream deprotection. Researchers use it to craft peptides requiring strict control over histidine reactivity. Its steric profile enables specialized synthetic workflows.
CAT No: R2166
CAS No:74853-62-6
Synonyms/Alias:74853-62-6;n,1-ditritylhistidine;2-(tritylamino)-3-(1-tritylimidazol-4-yl)propanoic acid;DTXSID60298663;NSC125175;Na,nim-ditrityl-L-histidine;DTXCID90249800;2-[(triphenylmethyl)amino]-3-[1-(triphenylmethyl)imidazol-4-yl]propanoic acid;AKOS024350629;NSC-125175;
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More